SpineGuard SA (ALSGD.PA)
| Previous close | 0.4500 |
| Open | 0.4502 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.4502 - 0.4700 |
| 52-week range | 0.4010 - 1.6740 |
| Volume | |
| Avg. volume | 129,531 |
| Market cap | 15.342M |
| Beta (5Y monthly) | 2.73 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0630 |
| Earnings date | 13 Oct 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.56 |
- Business Wire
SpineGuard Reports Third-quarter 2022 Revenue
PARIS & BOULDER, Colo., October 04, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today that its revenue was € 1.5 M in the third quarter up 44% and € 4.0 M YTD up 24%.
- Business Wire
SpineGuard Reports Six-Month 2022 Financial Results
PARIS & BOULDER, Colo., September 15, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today financial results for the half year ending June 30, 2022, as approved by the Board of Directors on September 15, 2022.
- Business Wire
Omnia Medical and SpineGuard Announce a Strategic Alliance for Adult Spine Surgery in the United States
MORGANTOWN, W.Va. & BOULDER, Colo. & PARIS, September 12, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, and Omnia Medical, a medical device company focused on innovative solutions utilizing proven techniques, announced today the signature of a co-development and exclusive distribution agreement for adult spine surgery in the United States
